Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W FINCHAM

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Therapeutic Drug Monitoring|January 1, 1979
Decreased phenytoin levels in antineoplastic therapyR W Fincham, D D Schottelius
Neurology|May 1, 1985
Bilateral focal cortical atrophy and chronic ergotamine abuseR W Fincham, Z Perdue, V D Dunn
Neurology|September 1, 1976
Use of phenytoin serum levels in a case of status epilepticusR W Fincham, D E Wiley, D D Schottelius
Neurology|December 1, 1975
Alexia with left homonymous hemianopia without agraphia. A case report with autopsy findingsR W Fincham, D W Nibbelink, C A Aschenbrener
The Annals of Pharmacotherapy|February 1, 1992
Parkinsonism treatment: Part III--UpdateD S Collier, M J Berg, R W Fincham
Journal of the American College of Cardiology|March 15, 1990
Bradycardia and syncope as manifestations of partial epilepsyL Constantin, J B Martins, R W Fincham, et al.
Epilepsia|July 1, 1992
Phenytoin pharmacokinetics: before and after folic acid administrationM J Berg, R W Fincham, B E Ebert, et al.
Epilepsia|January 1, 1988
Decrease of serum folates in healthy male volunteers taking phenytoinM J Berg, R W Fincham, B E Ebert, et al.
Therapeutic Drug Monitoring|December 1, 1987
Phenytoin binding in healthy volunteersM J Berg, B E Ebert, R W Fincham, et al.
Neurofibromatosis|January 1, 1988
Ventriculomegaly in neurofibromatosis-1. Association with Chiari type I malformationA K Afifi, K D Dolan, J C Van Gilder, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Therapeutic Drug Monitoring|January 1, 1979
Decreased phenytoin levels in antineoplastic therapyR W Fincham, D D Schottelius
Neurology|May 1, 1985
Bilateral focal cortical atrophy and chronic ergotamine abuseR W Fincham, Z Perdue, V D Dunn
Neurology|September 1, 1976
Use of phenytoin serum levels in a case of status epilepticusR W Fincham, D E Wiley, D D Schottelius
Neurology|December 1, 1975
Alexia with left homonymous hemianopia without agraphia. A case report with autopsy findingsR W Fincham, D W Nibbelink, C A Aschenbrener
The Annals of Pharmacotherapy|February 1, 1992
Parkinsonism treatment: Part III--UpdateD S Collier, M J Berg, R W Fincham
Journal of the American College of Cardiology|March 15, 1990
Bradycardia and syncope as manifestations of partial epilepsyL Constantin, J B Martins, R W Fincham, et al.
Epilepsia|July 1, 1992
Phenytoin pharmacokinetics: before and after folic acid administrationM J Berg, R W Fincham, B E Ebert, et al.
Epilepsia|January 1, 1988
Decrease of serum folates in healthy male volunteers taking phenytoinM J Berg, R W Fincham, B E Ebert, et al.
Therapeutic Drug Monitoring|December 1, 1987
Phenytoin binding in healthy volunteersM J Berg, B E Ebert, R W Fincham, et al.
Neurofibromatosis|January 1, 1988
Ventriculomegaly in neurofibromatosis-1. Association with Chiari type I malformationA K Afifi, K D Dolan, J C Van Gilder, et al.
Pageof 2